BACKGROUND: Current guidelines do not define the lower severity threshold for thrombolysis. In this study, we describe the variability of treatment of mild stroke patients across a network of academic stroke centers. METHODS: Stroke centers within the Specialized Program of Translational Research in Acute Stroke (SPOTRIAS) prospectively collect data on patients treated with intravenous recombinant tissue plasminogen activator (IV rt-PA), including demographics, pretreatment National Institutes of Health Stroke Scale (NIHSS) scores, and in-hospital mortality. We examined the variability in proportion of total tissue plasminogen activator-treated patients in the NIHSS categories (0-3, 4-5, or ≥ 6) and associated outcomes. RESULTS: A total of 2514 patients with reported NIHSS scores were treated with IV rt-PA between January 1, 2005 and December 31, 2009. The proportion of patients with mild stroke (NIHSS scores of 0-3) who were treated with IV rt-PA varied substantially across the centers (2.7-18.0%; P < .001). There were 5 deaths in the 256 treated with an NIHSS score of 0-3 (2.0%). The proportion of treated patients across the network with an NIHSS score of 0 to 3 increased from 4.8% in 2005 to 10.7% in 2009 (P = .001). CONCLUSIONS: There is substantial variability in the proportion of treated patients who have mild stroke across the SPOTRIAS centers, reflecting a paucity of data on how to best treat patients with mild stroke. Randomized trial data for this group of patients are needed to clarify the use of rt-PA in patients with the mildest strokes.
BACKGROUND: Current guidelines do not define the lower severity threshold for thrombolysis. In this study, we describe the variability of treatment of mild strokepatients across a network of academic stroke centers. METHODS:Stroke centers within the Specialized Program of Translational Research in Acute Stroke (SPOTRIAS) prospectively collect data on patients treated with intravenous recombinant tissue plasminogen activator (IV rt-PA), including demographics, pretreatment National Institutes of Health Stroke Scale (NIHSS) scores, and in-hospital mortality. We examined the variability in proportion of total tissue plasminogen activator-treated patients in the NIHSS categories (0-3, 4-5, or ≥ 6) and associated outcomes. RESULTS: A total of 2514 patients with reported NIHSS scores were treated with IV rt-PA between January 1, 2005 and December 31, 2009. The proportion of patients with mild stroke (NIHSS scores of 0-3) who were treated with IV rt-PA varied substantially across the centers (2.7-18.0%; P < .001). There were 5 deaths in the 256 treated with an NIHSS score of 0-3 (2.0%). The proportion of treated patients across the network with an NIHSS score of 0 to 3 increased from 4.8% in 2005 to 10.7% in 2009 (P = .001). CONCLUSIONS: There is substantial variability in the proportion of treated patients who have mild stroke across the SPOTRIAS centers, reflecting a paucity of data on how to best treat patients with mild stroke. Randomized trial data for this group of patients are needed to clarify the use of rt-PA in patients with the mildest strokes.
Authors: Eric E Smith; Abdul R Abdullah; Iva Petkovska; Eric Rosenthal; Walter J Koroshetz; Lee H Schwamm Journal: Stroke Date: 2005-10-06 Impact factor: 7.914
Authors: Urs Fischer; Adrian Baumgartner; Marcel Arnold; Krassen Nedeltchev; Jan Gralla; Gian Marco De Marchis; Liliane Kappeler; Marie-Luise Mono; Caspar Brekenfeld; Gerhard Schroth; Heinrich P Mattle Journal: Stroke Date: 2010-02-25 Impact factor: 7.914
Authors: H Christian Schumacher; Brian T Bateman; Bernadette Boden-Albala; Mitchell F Berman; J P Mohr; Ralph L Sacco; John Pile-Spellman Journal: Ann Emerg Med Date: 2007-05-03 Impact factor: 5.721
Authors: S B Coutts; C O'Reilly; M D Hill; N Steffenhagen; A Y Poppe; M J Boyko; V Puetz; A M Demchuk Journal: Int J Stroke Date: 2009-12 Impact factor: 5.266
Authors: Robert A Frank; Santanu Chakraborty; Trevor McGrath; Alexander Mungham; James Ross; Dar Dowlatshahi; Michel Shamy; Grant Stotts Journal: Neuroradiol J Date: 2018-05-03
Authors: Ilana Spokoyny; Rema Raman; Karin Ernstrom; Pooja Khatri; Dawn M Meyer; Thomas M Hemmen; Brett C Meyer Journal: J Stroke Cerebrovasc Dis Date: 2015-04-20 Impact factor: 2.136
Authors: Ava L Liberman; Daniel Pinto; Sara K Rostanski; Daniel L Labovitz; Andrew M Naidech; Shyam Prabhakaran Journal: Neurohospitalist Date: 2018-09-13